Anti-Aging Peptides

A growth hormone releasing hormone analog studied for stimulating growth hormone secretion.

A selective growth hormone secretagogue studied for targeted GH release with fewer side effects than other GH peptides.

A naturally occurring copper-binding peptide studied for skin regeneration, wound healing, and anti-aging effects.

A tetrapeptide studied for its potential to activate telomerase and influence biological aging markers.

A mitochondrial-derived peptide studied for metabolic regulation, exercise mimetic effects, and longevity.

A mitochondria-targeted peptide FDA-approved as FORZINITY (elamipretide) for Barth syndrome in September 2025 — the first FDA-approved mitochondrial-targeted therapeutic.

A hexapeptide analog studied for cognitive enhancement via hepatocyte growth factor pathway activation.

A senolytic peptide designed to selectively clear senescent cells by disrupting FOXO4-p53 interaction.

A GHRH analog FDA-approved for reducing visceral fat in HIV-associated lipodystrophy.

A GHRH analog previously FDA-approved for growth hormone deficiency diagnosis and treatment.

A long-acting GHRH analog with an extended half-life due to its Drug Affinity Complex modification.

A synthetic hexapeptide growth hormone secretagogue studied for its potent stimulation of growth hormone release via the ghrelin receptor.

A thymic peptide preparation studied for immune system rejuvenation and age-related immune decline.

A coenzyme essential for cellular energy production, studied for anti-aging and metabolic support.

A short bioregulatory peptide studied for neuroprotective effects and cognitive support in aging.

A cosmetic peptide studied for reducing the appearance of wrinkles by modulating muscle contraction signaling.

A multi-peptide blend of BPC-157, TB-500, and GHK-Cu formulated for tissue repair and skin rejuvenation.